6610 POSTER Safety of bevacizumab treatment in non-small cell lung cancer (NSCLC) subjects receiving full-dose anti-coagulation (FDAC) treated on protocol BO17704
Leighl, N., Bennouna, J., Kuo, H., Szima, B., Gottfried, M., Kunitsyn, A., Trigo, J., Chang, G., Cosaert, J., Reck, M.Volume:
5
Language:
english
Journal:
European Journal of Cancer Supplements
DOI:
10.1016/S1359-6349(07)71438-6
Date:
September, 2007
File:
PDF, 60 KB
english, 2007